380 related articles for article (PubMed ID: 24531137)
1. Survivin as a preferential target for cancer therapy.
Mobahat M; Narendran A; Riabowol K
Int J Mol Sci; 2014 Feb; 15(2):2494-516. PubMed ID: 24531137
[TBL] [Abstract][Full Text] [Related]
2. Survivin as a Potential Target for Cancer Therapy.
Soleimanpour E; Babaei E
Asian Pac J Cancer Prev; 2015; 16(15):6187-91. PubMed ID: 26434815
[TBL] [Abstract][Full Text] [Related]
3. Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin.
Kelly RJ; Lopez-Chavez A; Citrin D; Janik JE; Morris JC
Mol Cancer; 2011 Apr; 10():35. PubMed ID: 21470426
[TBL] [Abstract][Full Text] [Related]
4. Survivin in survival of hepatocellular carcinoma.
Su C
Cancer Lett; 2016 Sep; 379(2):184-90. PubMed ID: 26118774
[TBL] [Abstract][Full Text] [Related]
5. Treat cancers by targeting survivin: just a dream or future reality?
Coumar MS; Tsai FY; Kanwar JR; Sarvagalla S; Cheung CH
Cancer Treat Rev; 2013 Nov; 39(7):802-11. PubMed ID: 23453862
[TBL] [Abstract][Full Text] [Related]
6. Survivin-Based Treatment Strategies for Squamous Cell Carcinoma.
Santarelli A; Mascitti M; Lo Russo L; Sartini D; Troiano G; Emanuelli M; Lo Muzio L
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587347
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of apoptosis: clinical implications in cancer.
Mohamed MS; Bishr MK; Almutairi FM; Ali AG
Apoptosis; 2017 Dec; 22(12):1487-1509. PubMed ID: 29067538
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting the inhibitors: Targeting anti-apoptotic proteins in cancer and therapy resistance.
Shahar N; Larisch S
Drug Resist Updat; 2020 Sep; 52():100712. PubMed ID: 32599435
[TBL] [Abstract][Full Text] [Related]
9. Survivin as a prognostic/predictive marker and molecular target in cancer therapy.
Rödel F; Sprenger T; Kaina B; Liersch T; Rödel C; Fulda S; Hehlgans S
Curr Med Chem; 2012; 19(22):3679-88. PubMed ID: 22680927
[TBL] [Abstract][Full Text] [Related]
10. Targeting survivin for therapeutic discovery: past, present, and future promises.
Peery RC; Liu JY; Zhang JT
Drug Discov Today; 2017 Oct; 22(10):1466-1477. PubMed ID: 28577912
[TBL] [Abstract][Full Text] [Related]
11. Human breast cancer cells display different sensitivities to ABT-263 based on the level of survivin.
Lee EY; Gong EY; Shin JS; Moon JH; Shim HJ; Kim SM; Lee S; Jeong J; Gong JH; Kim MJ; Lee DH; Park YS; Shin J; Hong SW; Kim YS; Jin DH
Toxicol In Vitro; 2018 Feb; 46():229-236. PubMed ID: 28947240
[TBL] [Abstract][Full Text] [Related]
12. Clinico-pathologic relevance of Survivin splice variant expression in cancer.
Necochea-Campion Rd; Chen CS; Mirshahidi S; Howard FD; Wall NR
Cancer Lett; 2013 Oct; 339(2):167-74. PubMed ID: 23791888
[TBL] [Abstract][Full Text] [Related]
13. Clinical aspects for survivin: a crucial molecule for targeting drug-resistant cancers.
Singh N; Krishnakumar S; Kanwar RK; Cheung CH; Kanwar JR
Drug Discov Today; 2015 May; 20(5):578-87. PubMed ID: 25433305
[TBL] [Abstract][Full Text] [Related]
14. Monitoring survivin expression in cancer: implications for prognosis and therapy.
Santa Cruz Guindalini R; Mathias Machado MC; Garicochea B
Mol Diagn Ther; 2013 Dec; 17(6):331-42. PubMed ID: 23912862
[TBL] [Abstract][Full Text] [Related]
15. Targeting IAP (inhibitor of apoptosis) proteins for therapeutic intervention in tumors.
Vucic D
Curr Cancer Drug Targets; 2008 Mar; 8(2):110-7. PubMed ID: 18336193
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional regulation of the survivin gene.
Boidot R; Végran F; Lizard-Nacol S
Mol Biol Rep; 2014 Jan; 41(1):233-40. PubMed ID: 24197699
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
18. Targeting survivin in cancer: the cell-signalling perspective.
Kanwar JR; Kamalapuram SK; Kanwar RK
Drug Discov Today; 2011 Jun; 16(11-12):485-94. PubMed ID: 21511051
[TBL] [Abstract][Full Text] [Related]
19. Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells.
Castro-Gamero AM; Borges KS; Moreno DA; Suazo VK; Fujinami MM; de Paula Gomes Queiroz R; de Oliveira HF; Carlotti CG; Scrideli CA; Tone LG
Invest New Drugs; 2013 Aug; 31(4):858-70. PubMed ID: 23299390
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms of apoptosis and roles in cancer development and treatment.
Goldar S; Khaniani MS; Derakhshan SM; Baradaran B
Asian Pac J Cancer Prev; 2015; 16(6):2129-44. PubMed ID: 25824729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]